Keyphrases
Parkinson's Disease
100%
Apomorphine
100%
Sublingual
100%
APL-130277
100%
ON Response
75%
Adverse Events
50%
Off-state
50%
OFF Episodes
50%
Quality of Life
25%
Patients with Parkinson's Disease
25%
Parkinson Patients
25%
Proof of Concept Study
25%
Nausea
25%
Maximum Tolerated Dose
25%
Dizziness
25%
Somnolence
25%
Unified Parkinson's Disease Rating Scale (UPDRS)
25%
On-state
25%
Non-invasive Treatment
25%
Trimethobenzamide
25%
Oral Strip
25%
Nursing and Health Professions
Parkinson's Disease
100%
Apomorphine
100%
Adverse Event
66%
Non Invasive Procedure
33%
Somnolence
33%
Nausea
33%
Dizziness
33%
Unified Parkinson's Disease Rating Scale
33%
Myelodysplastic Syndrome
33%
Maximum Permissible Dose
33%
Trimethobenzamide
33%
Quality of Life
33%
Medicine and Dentistry
Parkinson's Disease
100%
Apomorphine
100%
Adverse Event
66%
Quality of Life
33%
Non Invasive Procedure
33%
Somnolence
33%
Nausea
33%
Myelodysplastic Syndrome
33%
Dizziness
33%
Unified Parkinson's Disease Rating Scale
33%
Trimethobenzamide
33%
Oral
33%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Apomorphine
100%
Adverse Event
66%
Myelodysplastic Syndrome
33%
Somnolence
33%
Nausea
33%
Dizziness
33%
Trimethobenzamide
33%
Neuroscience
Parkinson's Disease
100%
Apomorphine
100%
Somnolence
33%
Trimethobenzamide
33%
Quality of Life
33%